Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q3 2025 Earnings

Aug 29Confirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
0.02
0.14
0.26
0.38

Details

Expected EPS
0.02175255162
Actual EPS
0.19577296458
Surprise EPS
0.17
Surprise Percent
+800%

Description

⁨Shenzhen Hepalink Pharmaceutical Group.⁩ (⁦9989.HK⁩) has reported earnings of ⁦0.19577296458⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts